Clinicians tend to view obesity as a disease, while members of the body positivity movement value their bodies as they are. Should clinicians treat obesity as a disease in patients who don’t see themselves as ill?
AMA J Ethics. 2018;20(12):E1195-1200. doi:
10.1001/amajethics.2018.1195.
Haley Moulton, Benjamin Moulton, JD, MPH, Tim Lahey, MD, MMSc, and Glyn Elwyn, MD, PhD, MSc
Shared decision making in research informed consent conversations is complex due to diverse and potentially divergent interests of investigators and patient-subjects.
AMA J Ethics. 2020;22(5):E365-371. doi:
10.1001/amajethics.2020.365.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.
Wandy D. Hernandez-Gordon, CD(DONA), BDT(DONA), CLC, CCE(ACBE)
CHWs’ work underscores need for clinicians and organizations to respond to deeply entrenched, long-standing patterns of oppression in ways that draw upon lived experience.
AMA J Ethics. 2022;24(4):E333-339. doi:
10.1001/amajethics.2022.333.
Until the mid-20th century, birth in the United States for Latinx Indigenous peoples was an ancestral ceremony guided by midwives and traditional healers.
AMA J Ethics. 2022;24(4):E326-332. doi:
10.1001/amajethics.2022.326.
Dr Stephen P. Richmond joins Ethics Talk to discuss his article, coauthored with Dr Vanessa Grubbs: “How Abolition of Race-Based Medicine Is Necessary to American Health Justice.”